Prime Medicine PRME
NASDAQ PRME
$3.79 -0.02 (-0.50%)
As of: Oct 22, 2026 · 9:35 AM EDT

Prime Medicine (PRME) Other Operating Expenses (2023)

Updated

Prime Medicine (PRME) recorded Other Operating Expenses of $13.5 million in Q4 2023.

Analysis

Prime Medicine (PRME) Other Operating Expenses (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn
10 Prime Medicine 670.97 Mn 49.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 13.50 Mn
API Access

Prime Medicine Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=PRME&period=max&api_key=YOUR_API_KEY